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Case Report
Radiographic development during three
decades in a patient with psoriatic
arthritis mutilans
Leena Laasonen1, Bjo¨rn Gubjo¨rnsson2, Leif Ejstrup3,
Lars Iversen4, Thomas Ternowitz5, Mona Sta˚hle6 and
Ulla Lindqvist7
Abstract
Psoriatic arthritis mutilans (PAM) is the most severe and rare form of psoriatic arthritis (PsA). We describe radiological
development in a typical case of PAM covering three decades in order to elucidate the need for early diagnosis of PAM.
Radiographs of hands and feet, taken from 1981 to 2010, were evaluated using the Psoriatic Arthritis Ratingen Score
(PARS). When PsA was diagnosed, in 1981, gross deformity was observed in the second PIP joint of the left foot. Several
pencil-in-cup deformities and gross osteolysis were present in the feet in the first decade of the disease. Over 10 years,
many joints had reached maximum scores. During the follow-up, other joints became involved and the disease developed
clinically. Reporting early signs suggestive of PAM, e.g. pencil-in cup deformities and gross osteolysis in any joint, should
be mandatory and crucial. This would heighten our awareness of PAM, accelerate the diagnosis, and lead to improved
effective treatment in order to minimize joint damages resulting in PAM.
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Introduction
Psoriatic arthritis mutilans (PAM) is the most severe
form of the ﬁve clinical presentations of psoriatic
arthritis (PsA) described by Moll and Wright (1). The
clinical manifestation of the condition is shortening of a
digit due to gross osteolysis, resulting in the so-called
‘‘opera glass ﬁnger’’, ‘‘telescopic ﬁnger’’, or ‘‘doigt en
lorgnette’’. Previously published studies on this condi-
tion have used diﬀerent deﬁnitions of PAM, as no inter-
national classiﬁcation criteria are yet to be found in the
literature. However, radiographic features have been
found to be more sensitive than clinical ﬁndings (2).
Recently, attempts have been made on the initiative
of the Group for Research and Assessment of
Psoriasis and Psoriatic Arthritis (GRAPPA) in order
to develop a consensus deﬁnition of PAM, but these
have not yet been globally accepted (2).
The reported prevalence of PAM varies
considerably, in the range of 1–21% of patients with
PsA (3–6). In the Nordic countries, the prevalence was
found to be only about four cases per 1,000,000 inhab-
itants (3.7; 95% CI 2.8–4.6) in a multinational
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population-based study recently published by the
Nordic PAM Study Group (7).
Radiographic evaluation is helpful and conventional
radiographs are the most commonly used radiological
tool. The radiographic features of PsA are well known,
including joint destruction, inter-joint space narrowing,
bony proliferation, periostitis, osteolysis, including
pencil-in-cup deformity, and ankylosis. Any or all of
these radiological changes may be present in one and
the same patient. Involvement of the distal interphalan-
geal joints of the ﬁngers is typical (8). Osteolysis is the
deﬁning feature of PAM and there is consensus (accord-
ing to GRAPPA) that involvement of a single joint is
suﬃcient to establish the diagnosis of PAM (2,9).
In this case report we present the radiographic ﬁnd-
ings of an almost 30-year follow-up in a patient aﬄicted
by PAM.
Case report
The patient gave his written informed consent for this
case presentation. The Bioethics and Data Protection
Committees in all four countries approved the study
protocol for the Nordic PAM study.
The patient was a 58-year-old man with a 34-year
history of psoriasis. Serological tests showed that he
was HLA-B27 positive and had a low titer of antinuc-
lear antibodies (ANA) (1/200), though rheumatoid
factor (RF) and anti-cyclic citrullinated peptide antibo-
dies (ACPA) proved negative. Polyarthritis was
reported at the age of 25 years. As psoriasis had been
diagnosed 1 year prior to the appearance of joint symp-
toms, a diagnosis of PsA was made. During the ﬁrst 10
years the patient was treated with NSAIDs, and in
1988, 9 years after PsA diagnosis, he was prescribed
sulphasalazine, by which time dactylitis had aﬀected
all ﬁngers. However, due to adverse reactions, this
treatment was discontinued only a few months later.
After 4 more years of NSAID treatment, methotrexate
was initiated, ﬁrst at a low dose combined with numer-
ous local steroid injections. Later the patient accepted a
methotrexate dosage of 12.5mg/week. Since 2001 he
has been treated with a TNF- inhibitor (inﬂiximab)
combined with methotrexate. Between 1979 and 2001
he suﬀered from active polyarthritis with increased
ESR and CRP values, but since the initiation of
TNF- inhibitor therapy the joints have not been
inﬂamed and the ESR and CRP values have both
been within the reference range. The diagnosis of
PAM was ﬁrst established in this patient’s record in
1997, 18 years after the PsA diagnosis.
Six sets of radiographs of the hands and feet were
available from 1981, 1988, 1991, 2001, 2005, and 2010.
All were assessed by the same reader (EL) according to
the Psoriatic Arthritis Ratingen Score (PARS) (10).
An annual progression rate (ProgrR, units/year) was
also calculated. This scoring method was developed
speciﬁcally for the radiographic assessment of PsA.
Distal interphalangeal (DIP)/interphalangeal (IP),
proximal interphalangeal (PIP), metacarpophalangeal
(MCP) joints, wrists, IP joint of the great toe, and
metatarsophalangeal (MTP) joints 2–5 were assessed
for degree of destruction (destruction score, DS) on a
0 to 5-point scale and proliferation (proliferation score,
PS) on a 0–4 scale. The maximum scores were thus 200
for DS and 160 for PS, with a total score of 360 for
each patient. The results of the radiographic PARS
scoring are presented in Table 1. The progression rate
was most pronounced between 1981 and 1991 both in
hands and in feet but after initiation of the TNF-
inhibitor, the progression slowed.
In the PARS scoring method, pedal PIP and DIP
joints are not rated at all. In the current case, pedal
IP joints were noted separately. As early as 1981
gross deformity was observed in the second PIP joint
of the left foot. Pencil-in-cup deformities and gross
osteolysis were present in two pedal PIP and DIP
joints at the 1988 examination (Fig. 1a–d). Plantar
enthesophytes were observed already at the ﬁrst exam-
ination but did not progress over time. Fig. 2 shows
typical dactylitic changes in the third ﬁnger of the left
hand.
Discussion
This case report presents the natural course of events in
a patient suﬀering from PsA, developing to PAM,
untreated for decades. The clinical pattern of PsA
often changes during the course of disease, as does
the radiological pattern, and both need to be taken
into clinical consideration (11). Had the radiological
pattern of PAM been included, the diagnosis could
Table 1. Psoriatic Arthritis Ratingen Scores of a patient with
psoriatic arthritis mutilans in hands and feet visualized in serial
radiographs from 1981 through 2010.
DS PS
Total PR Units/yearHands Feet Hands Feet
1981 0 0 0 0 0
1988 26 23 12 10 71 10.1
1991 47 33 18 17 115 14.6
2001 87 59 22 18 186 2.7
2005 92 59 22 19 192 1.5
2010 92 59 23 19 193 0.3
DS, destruction score; PR, progression rate; PS, proliferation score; Total,
total score.
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have been made as early as in 1988, or 9 years previ-
ously, i.e. instead of 1997 when the diagnosis of PAM
was ﬁrst mentioned.
It is important to include all proximal and distal
joints of hands and feet in a patient’s PsA assessment.
In the present case the most severe progression was seen
in the feet, even during the ﬁrst decade of disease.
Progression of the PIP joint changes was pronounced.
Inclusion of the pedal PIP and DIP joints in radio-
graphic scores might be of advantage, but the assess-
ment of these joints is diﬃcult on conventional
radiographs for technical reasons, i.e. because of over-
lapping structures. However, the radiologist should
report any sign suggesting PAM, such as gross osteoly-
sis and pencil-in-cup deformities in any joint, and thus
alert the clinician of a likely diagnosis of PAM.
The degree of destruction in PsA can be demon-
strated by using a scoring system, as used in clinical
trials. Feasibility, reliability, and sensitivity to change
have been evaluated for four diﬀerent radiographic
scoring methods in 50 patients with PsA (12).
Two assessors rated the radiographs by modiﬁed
Steinbrocker scoring (STB), modiﬁed Sharp scor-
ing (MSS), the modiﬁed Sharp–van der Heijde method
(SvdH) and Psoriatic Arthritis Ratingen scoring
(PARS). The SvdH method proved the most reliable
and sensitive to changes, but took longest to perform by
the observer. The PARS method, initially developed for
PsA, was close to the SvdH and much quicker to per-
form. The smallest detectable changes were 2.9% (STB),
2.1% (MSS), 1.4% (SvdH), and 1.2% (PARS). PARS
was therefore chosen to assess the progression of
destruction in the present case. However, none of these
methods include special scoring for mutilans changes;
nor do they take pedal PIP and DIP joints into account.
There are relatively few published studies where
radiographic scoring methods were applied to assess
the progression of PsA. Ravindran et al. (13) studied
Fig. 1. Serial radiographs from 1981 (a), 1988 (b), 2001 (c) through 2010 (d), showing typical changes of psoriatic arthritis mutilans in
the left foot of a 58-year-old male patient.
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139 patients with established PsA and a median follow-
up of 5.7 years, using the MSS. Their median progres-
sion score was þ1.08 units/year. They found a close
correlation between MSS and clinical joint scores,
and other characteristic radiographic features of PsA.
In the present case, with a follow-up of 29 years, the
most rapid progression was seen early in the disease
course, i.e. during the ﬁrst decade, after which the
radiological progress declined. Thus, prompt radio-
logical assessment of patients with early PsA is manda-
tory. Importantly, many joints had, after only 10 years,
reached maximum scores, although the joint damage
still showed progression in the subsequent years,
though fewer additional joints were then involved.
Thus, the treatment with an TNF- inhibitor in this
present case may have slowed the progression of joint
destruction (14).
In conclusion, awareness of any radiological sign of
mutilans joint damage in PsA may lead to early recog-
nition of PAM, to be followed by early aggressive treat-
ment which may prevent severe joint destruction of the
mutilans type seen in patients aﬀected by PsA.
Radiographic scoring methods can be used to assess
progression in PsA but need to be further developed
for assessment of PAM.
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